
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter C - Drugs: General
#### PART 201 - LABELING
##### Subpart B - Labeling Requirements for Prescription Drugs and/or Insulin
###### ยง 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in ยง 201.56(b)(1).
####### 1,Disease-associated maternal and/or embryo/fetal risk.

()If there is a serious known or potential risk to the pregnant woman and/or the embryo/fetus associated with the disease or condition for which the drug is indicated to be used, the labeling must describe the risk.
